- Corporate Officers - D
- Duncan Barbara Gayle
Insider Trading History of Duncan Barbara Gayle
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Duncan Barbara Gayle since 2015.
This trader's CIK number is 1353128.
At the time of last reporting, Duncan Barbara Gayle was the Officer of Atea Pharmaceuticals, Inc.. (stock ticker symbol AVIR).
Also see all insider trading activities at Atea Pharmaceuticals, Inc..
Note that in the past
Duncan Barbara Gayle also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Intercept Pharmaceuticals, Inc. (ICPT) by Duncan Barbara Gayle
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2016 | ICPT | 0 | $0 | 905 | $132,287 | 1,298 | $0 |
| 2015 | ICPT | 0 | $0 | 4,287 | $907,730 | 8,192 | $50,524 |
Yearly summary of insider trading at Atea Pharmaceuticals, Inc. (AVIR) by Duncan Barbara Gayle
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2025 | AVIR | 0 | $0 | 0 | $0 | 29,600 | $0 |
| 2024 | AVIR | 0 | $0 | 0 | $0 | 33,150 | $0 |
Yearly summary of insider trading at Aevi Genomic Medicine, Llc (GNMX) by Duncan Barbara Gayle
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2017 | GNMX | 59,524 | $75,000 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Immunomedics Inc (IMMU) by Duncan Barbara Gayle
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2020 | IMMU | 0 | $0 | 0 | $0 | 39,577 | $602,405 |
Yearly summary of insider trading at Jounce Therapeutics, Inc. (JNCE) by Duncan Barbara Gayle
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2020 | JNCE | 0 | $0 | 10,000 | $100,000 | 10,000 | $42,100 |
| 2018 | JNCE | 0 | $0 | 6,000 | $156,220 | 6,000 | $25,260 |
Insider trading activities at 5 companies by Duncan Barbara Gayle:
1. Intercept Pharmaceuticals, Inc. (ICPT)
2. Atea Pharmaceuticals, Inc. (AVIR)
3. Aevi Genomic Medicine, Llc (GNMX)
4. Immunomedics Inc (IMMU)
5. Jounce Therapeutics, Inc. (JNCE)
Table 1. Insider trading of Intercept Pharmaceuticals, Inc. (ICPT) by Duncan Barbara Gayle
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2016-10-03 | ICPT | Sale | 147 | 163.20 | 23,990 |
| 2016-07-05 | ICPT | Sale | 146 | 145.11 | 21,185 |
| 2016-04-04 | ICPT | Sale | 144 | 130.76 | 18,829 |
| 2016-01-01 | ICPT | Option Ex | 1,298 | .00 | 0 |
| 2016-01-04 | ICPT | Sale | 468 | 145.90 | 68,283 |
| 2015-10-01 | ICPT | Option Ex | 2,298 | 4.33 | 9,957 |
| 2015-10-01 | ICPT | Sale | 1,000 | 163.39 | 163,390 |
| 2015-10-02 | ICPT | Sale | 54 | 159.04 | 8,588 |
| 2015-07-01 | ICPT | Option Ex | 1,298 | .00 | 0 |
| 2015-07-02 | ICPT | Sale | 53 | 237.76 | 12,601 |
| 2015-07-01 | ICPT | Sale | 1,000 | 242.10 | 242,100 |
| 2015-07-01 | ICPT | Option Ex | 1,000 | 8.67 | 8,667 |
| 2015-04-01 | ICPT | Option Ex | 1,298 | .00 | 0 |
| 2015-04-02 | ICPT | Sale | 39 | 277.70 | 10,830 |
| 2015-03-27 | ICPT | Sale | 1,000 | 288.94 | 288,937 |
| 2015-01-05 | ICPT | Sale | 141 | 176.49 | 24,884 |
| 2015-01-01 | ICPT | Option Ex | 1,298 | .00 | 0 |
| 2015-01-02 | ICPT | Option Ex | 1,000 | 31.90 | 31,900 |
| 2015-01-02 | ICPT | Sale | 1,000 | 156.40 | 156,400 |
Table 2. Insider trading of Atea Pharmaceuticals, Inc. (AVIR) by Duncan Barbara Gayle
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2025-06-20 | AVIR | Option Ex | 29,600 | .00 | 0 |
| 2024-06-16 | AVIR | Option Ex | 33,150 | .00 | 0 |
Table 3. Insider trading of Aevi Genomic Medicine, Llc (GNMX) by Duncan Barbara Gayle
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2017-10-17 | GNMX | Buy | 59,524 | 1.26 | 75,000 |
Table 4. Insider trading of Immunomedics Inc (IMMU) by Duncan Barbara Gayle
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2020-09-14 | IMMU | Option Ex | 2,500 | 16.96 | 42,400 |
| 2020-08-17 | IMMU | Option Ex | 20,000 | 16.96 | 339,200 |
| 2020-08-12 | IMMU | Option Ex | 17,077 | 12.93 | 220,805 |
Table 5. Insider trading of Jounce Therapeutics, Inc. (JNCE) by Duncan Barbara Gayle
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2020-09-15 | JNCE | Option Ex | 10,000 | 4.21 | 42,100 |
| 2020-09-15 | JNCE | Sale | 10,000 | 10.00 | 100,000 |
| 2018-03-15 | JNCE | Sale | 2,000 | 28.11 | 56,220 |
| 2018-03-15 | JNCE | Option Ex | 2,000 | 4.21 | 8,420 |
| 2018-01-26 | JNCE | Option Ex | 4,000 | 4.21 | 16,840 |
| 2018-01-26 | JNCE | Sale | 4,000 | 25.00 | 100,000 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Duncan Barbara Gayle
(Officer of Atea Pharmaceuticals, Inc. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.